In line with this observation, Webber et al., noticed that second to CD38 expression, AML blasts most frequently expressed the myeloid lineage markers CD13 (91%) and CD33 (87%) (Webber et al., 2008). The gene discussed is CD33; the disease is acute myeloid leukemia.